Diabetes and Endocrinology Symposium: Clinical challenges and expert advice

1 Mitchell AL Pearce SHS. How should we treat patients with low serum thyrotropin concentrations? Clin Endocrinol (Oxf) 2009; Epub ahead of print.

2The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in Type 2 diabetes. N Engl J Med 2008; 358:2545–59.

3The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N Engl J Med 2008; 358:2560–72.

4 Meier JJ Bhushan A Butler PC. The potential for stem cell therapy in diabetes. Pediatr Res 2006; 59:65–73.

5 Butler PC Meier JJ Butler AE The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 2007; 3:758–68.

6 Hambly H Robling M Crowne E Communication skills of healthcare professionals in paediatric diabetes services. Diabet Med 2009; 26:502–9.

7 Ferrari GL Marques JL Gandhi RA An approach to the assessment of diabetic neuropathy based on dynamic pupillometry. Conf Proc IEEE Eng Med Biol Soc 2007; 557–60.

8 Leese GP. The varied attractions of the diabetic foot. Br J Diabetes Vasc Dis 2009; 9:155–9.